Pilot Study of Imatinib Cetuximab Combo for H & N Cancer

Clinical trial NCT05816785 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05816785
Sponsor: University of Wisconsin, Madison
Status: ACTIVE_NOT_RECRUITING
Phase: Early Phase 1
Study type: INTERVENTIONAL

Head and Neck Cancer Squamous Cell Carcinoma of Head and Neck

Start date: 2023-04-18
Primary completion: 2026-10-31
Enrollment: 15

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.